AG
IMVT icon

Algert Global’s Immunovant IMVT Stock Holding History

Algert Global’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.63M Buy
+105,770
New +$2.74M 0.04% 640
2025
Q4 		– Sell
-34,900
Closed -$563K – 1228
2025
Q3 		$563K Buy
+34,900
New +$565K 0.01% 915
2024
Q4 		– Sell
-36,969
Closed -$1.05M – 1244
2024
Q3 		$1.05M Sell
36,969
-83,969
-69% -$2.48M 0.03% 736
2024
Q2 		$3.19M Buy
120,938
+69,278
+134% +$1.97M 0.11% 311
2024
Q1 		$1.67M Buy
51,660
+1,999
+4% +$72.9K 0.07% 472
2023
Q4 		$2.09M Sell
49,661
-13,808
-22% -$508K 0.08% 401
2023
Q3 		$2.44M Sell
63,469
-16,190
-20% -$366K 0.11% 299
2023
Q2 		$1.51M Buy
79,659
+40,470
+103% +$755K 0.07% 501
2023
Q1 		$608K Buy
+39,189
New +$680K 0.03% 775
2022
Q4 		– Sell
-82,741
Closed -$462K – 1197
2022
Q3 		$462K Sell
82,741
-43,459
-34% -$212K 0.03% 825
2022
Q2 		$492K Sell
126,200
-10,127
-7% -$43.7K 0.04% 768
2022
Q1 		$751K Buy
+136,327
New +$849K 0.05% 649
2021
Q3 		– Sell
-28,710
Closed -$303K – 1044
2021
Q2 		$303K Sell
28,710
-38,403
-57% -$536K 0.1% 286
2021
Q1 		$1.08M Buy
+67,113
New +$1.77M 0.34% 101

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Algert Global's IMVT Position: Q1 2026 in Review

Algert Global opened a new position in Immunovant (IMVT) in Q1 2026: 105,770 shares worth $2.63M. The stake represents 0.04% of the portfolio and ranks #640 among its holdings. This is a return to the name: Algert Global previously reported a position in IMVT as recently as Q3 2025.

Algert Global first reported a position in IMVT in Q1 2021 and has held it in 14 quarters since. The position peaked at $3.19M in Q2 2024. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Algert Global held 105,770 shares of Immunovant worth $2.63M as of Q1 2026.
  • Immunovant was a new Algert Global position in Q1 2026.
  • Immunovant made up 0.04% of Algert Global's portfolio in Q1 2026, its #640 holding.
  • Algert Global first reported a position in Immunovant in Q1 2021 and has held it in 14 quarters since.
  • Algert Global's Immunovant position peaked at $3.19M in Q2 2024.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.